TenNor Therapeutics is based in Suzhou, China. It has raised $109M in total funding. Latest round: Series B.
TenNor Therapeutics is based in Suzhou, China. TenNor Therapeutics has raised $109M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2016. The round record for TenNor Therapeutics runs through 2016; nothing later has been disclosed. Investors on record include Northern Light Venture Capital, Frontline BioVentures, WuXi PharmaTech Healthcare Fund I, Oriza Venture Capital, Relativity Healthcare Fund. 5 distinct backers are named across the disclosed rounds.
Round data for TenNor Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Suzhou and backer lists below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026